Short Interest in United-Guardian, Inc. (NASDAQ:UG) Rises By 26.7%

United-Guardian, Inc. (NASDAQ:UGGet Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 13,300 shares, a growth of 26.7% from the September 15th total of 10,500 shares. Based on an average trading volume of 20,400 shares, the short-interest ratio is currently 0.7 days. Currently, 0.5% of the shares of the company are sold short.

United-Guardian Stock Up 11.0 %

United-Guardian stock traded up $1.40 during trading on Monday, reaching $14.08. The stock had a trading volume of 26,922 shares, compared to its average volume of 12,457. United-Guardian has a 52-week low of $5.79 and a 52-week high of $16.25. The business has a 50 day moving average price of $13.72 and a 200 day moving average price of $10.73. The stock has a market cap of $64.63 million, a PE ratio of 23.33 and a beta of 0.82.

United-Guardian (NASDAQ:UGGet Free Report) last released its quarterly earnings data on Friday, August 9th. The company reported $0.21 earnings per share for the quarter. The company had revenue of $3.39 million for the quarter. United-Guardian had a net margin of 26.36% and a return on equity of 28.64%.

Institutional Investors Weigh In On United-Guardian

Several hedge funds have recently modified their holdings of UG. Renaissance Technologies LLC grew its position in United-Guardian by 1.1% in the second quarter. Renaissance Technologies LLC now owns 187,563 shares of the company’s stock valued at $1,677,000 after acquiring an additional 2,100 shares in the last quarter. Rodgers Brothers Inc. boosted its holdings in United-Guardian by 5.0% in the first quarter. Rodgers Brothers Inc. now owns 100,100 shares of the company’s stock worth $766,000 after purchasing an additional 4,750 shares during the period. Finally, Essex Investment Management Co. LLC bought a new stake in United-Guardian in the third quarter valued at $126,000. 23.16% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on shares of United-Guardian in a research report on Monday, August 26th. They issued a “buy” rating for the company.

Get Our Latest Research Report on UG

About United-Guardian

(Get Free Report)

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Further Reading

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.